| A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases RC Coll, AAB Robertson, JJ Chae, SC Higgins, R Muñoz-Planillo, ... Nature medicine 21 (3), 248-255, 2015 | 2342 | 2015 |
| The role of natural product chemistry in drug discovery MS Butler Journal of natural products 67 (12), 2141-2153, 2004 | 2194 | 2004 |
| Natural products to drugs: natural product-derived compounds in clinical trials MS Butler Natural product reports 25 (3), 475-516, 2008 | 1139 | 2008 |
| Natural products to drugs: natural product derived compounds in clinical trials MS Butler Natural product reports 22 (2), 162-195, 2005 | 804 | 2005 |
| Natural product and natural product derived drugs in clinical trials MS Butler, AAB Robertson, MA Cooper Natural product reports 31 (11), 1612-1661, 2014 | 646 | 2014 |
| Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice R Gordon, EA Albornoz, DC Christie, MR Langley, V Kumar, S Mantovani, ... Science translational medicine 10 (465), eaah4066, 2018 | 603 | 2018 |
| Antibiotics in the clinical pipeline in 2013 MS Butler, MA Blaskovich, MA Cooper The Journal of antibiotics 66 (10), 571-591, 2013 | 553 | 2013 |
| Natural products—the future scaffolds for novel antibiotics? MS Butler, AD Buss Biochemical pharmacology 71 (7), 919-929, 2006 | 549 | 2006 |
| Antibiotics in the clinical pipeline at the end of 2015 MS Butler, MAT Blaskovich, MA Cooper The Journal of antibiotics 70 (1), 3-24, 2017 | 422 | 2017 |
| Antibiotics in the clinical pipeline in 2011 MS Butler, MA Cooper The Journal of antibiotics 64 (6), 413-425, 2011 | 349 | 2011 |
| Glycopeptide antibiotics: back to the future MS Butler, KA Hansford, MAT Blaskovich, R Halai, MA Cooper The Journal of antibiotics 67 (9), 631-644, 2014 | 309 | 2014 |
| Antibiotics in the clinical pipeline in October 2019 MS Butler, DL Paterson The Journal of antibiotics 73 (6), 329-364, 2020 | 273 | 2020 |
| Developments in glycopeptide antibiotics MAT Blaskovich, KA Hansford, MS Butler, ZG Jia, AE Mark, MA Cooper ACS Infectious Diseases 4 (5), 715-735, 2018 | 242 | 2018 |
| Analysis of the clinical antibacterial and antituberculosis pipeline U Theuretzbacher, S Gottwalt, P Beyer, M Butler, L Czaplewski, ... The Lancet Infectious Diseases 19 (2), e40-e50, 2019 | 238 | 2019 |
| Identification of chelerythrine as an inhibitor of BclXL function SL Chan, MC Lee, KO Tan, LK Yang, ASY Lee, H Flotow, NY Fu, ... Journal of Biological Chemistry 278 (23), 20453-20456, 2003 | 231 | 2003 |
| Dragmacidins: New Protein Phosphatase Inhibitors from a Southern Australian Deep-Water Marine Sponge, Spongosorites sp. RJ Capon, F Rooney, LM Murray, E Collins, ATR Sim, JAP Rostas, ... Journal of natural products 61 (5), 660-662, 1998 | 200 | 1998 |
| Analysis of the clinical pipeline of treatments for drug-resistant bacterial infections: despite progress, more action is needed MS Butler, V Gigante, H Sati, S Paulin, L Al-Sulaiman, JH Rex, ... Antimicrobial agents and chemotherapy 66 (3), e01991-21, 2022 | 155 | 2022 |
| Activity and predicted nephrotoxicity of synthetic antibiotics based on polymyxin B A Gallardo-Godoy, C Muldoon, B Becker, AG Elliott, LH Lash, JX Huang, ... Journal of medicinal chemistry 59 (3), 1068-1077, 2016 | 144 | 2016 |
| Circumdatin G, a New Alkaloid from the Fungus Aspergillus ochraceus JR Dai, BK Carté, PJ Sidebottom, AL Sek Yew, SB Ng, Y Huang, ... Journal of Natural Products 64 (1), 125-126, 2001 | 142 | 2001 |
| Lamellarins O and P: New aromatic metabolites from the Australian marine sponge Dendrilla cactos S Urban, MS Butler, RJ Capon Australian Journal of Chemistry 47 (10), 1919-1924, 1994 | 130 | 1994 |
Matthew A. CooperThe University of Cambridge在 cam.ac.uk 的电子邮件经过验证
